EU-Authorized Desana Biocides: What Manufacturers and Distributors Must Do in 2026

Key data

Manufacturers, distributors, and professional users of biocides in the EU have had a new mandatory regulatory reference since 16 July 2026. The Commission Implementing Regulation (EU) 2026/1737 grants Union authorization for the BPF THO TM Desana biocide family, under Regulation (EU) No 528/2012, the European regulatory framework governing the marketing and use of biocidal products.

This authorization is not a minor formality: it defines exactly what uses are legal, how the product must be labeled, and what restrictions apply. Operating outside those limits exposes the company to administrative penalties and product market withdrawal.

What does this regulation establish?

Commission Implementing Regulation (EU) 2026/1737 grants a Union authorization for the BPF THO TM Desana biocide family. This means the product is enabled for marketing and use in all EU Member States under a single centralized authorization, without each country needing to issue its own national authorization.

This mechanism, provided for in Regulation (EU) No 528/2012, simplifies access to the European single market for the authorization holder. However, administrative simplification is accompanied by strict conditions that must be respected throughout the value chain:

• Labeling: the product must be labeled in accordance with the specifications set out in the granted authorization.
• Permitted uses: only uses expressly authorized in the regulation may be carried out. Any use outside that scope is illegal.
• Specific restrictions: the authorization includes specific restrictions affecting how, where, and by whom the product may be used.
• Application sectors: the authorization has direct relevance for the disinfection, pest control, and industrial treatment sectors.

Non-compliance with any of these conditions may result in administrative penalties and market withdrawal of the affected product.

Economic and operational impact

The single EU authorization has a dual reading for companies in the sector:

Commercial opportunity: the authorization holder gains direct access to the European single market without having to manage national authorizations in each of the 27 Member States. This reduces administrative costs, shortens time-to-market, and facilitates international product expansion.

Compliance obligation: in return, the authorization conditions are unique and non-negotiable at national level. Manufacturers and distributors must adapt their processes, labeling, and technical documentation to the requirements established in Regulation (EU) 2026/1737. Any deviation, even in a single Member State, can compromise the validity of the authorization throughout the EU.

For professional users —disinfection companies, pest control, industrial treatment— the impact is operational: they must verify that their use of the product complies exactly with the authorized uses. Using the biocide for an application not covered by the authorization is an infraction, regardless of whether the product is legally on the market.

Who does it affect?

• Manufacturers of the BPF THO TM Desana biocide family: must ensure that production, labeling, and technical documentation comply with the conditions of the granted authorization.
• Distributors marketing this product in any EU Member State: must verify that the product they distribute is correctly labeled and is not marketed for unauthorized uses.
• Professional users in the disinfection, pest control, and industrial treatment sectors: must verify that their use protocols comply with the uses permitted by the authorization.
• Compliance officers (compliance officers, quality managers, legal advisors) of companies operating with biocides in the EU.
• Importers and exporters of biocidal products within the European single market.

Practical example

A Spanish pest control company using products from the BPF THO TM Desana family in its disinfection services must, as of 16 July 2026, review its technical data sheets and internal protocols to confirm that the uses it performs are expressly covered by the Union authorization granted by Regulation (EU) 2026/1737.

If the company applies the biocide in a context —for example, a type of facility or a concentration— that is not among the authorized uses, it would be in breach of regulatory requirements even though the product is legally marketed. This may result in an inspection, an administrative penalty, or a prohibition on using the product in its operations.

Similarly, a distributor selling this biocide to industrial customers must ensure that the labeling of the product it delivers complies with the specifications of the EU authorization, and not with earlier versions or national adaptations that may have become outdated.

What should companies do now?

1. Identify if the product affects your activity: check if you manufacture, distribute, or professionally use any product from the BPF THO TM Desana family. If so, this regulation applies directly to you from 16 July 2026.
2. Review the full text of the authorization: access Commission Implementing Regulation (EU) 2026/1737 in the EU Official Journal and identify the authorized uses, specific restrictions, and labeling requirements.
3. Update product labeling: if you are a manufacturer or distributor, verify that current labeling complies with the conditions of the new Union authorization. If there are discrepancies, correct them before continuing marketing.
4. Review internal use protocols: if you are a professional user, compare your operating procedures with the uses permitted in the authorization. Document that verification.
5. Inform your supply chain: distributors and professional customers must be aware of the authorization conditions to avoid non-compliant uses that could compromise the product's validity on the market.
6. Consult with a biocide regulation specialist if you have doubts about whether your current uses are covered by the granted authorization, especially if you operate in multiple Member States.

Official source

View complete regulation at official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202601737